The forecast for musculo-skeletal system medicine sales in Germany shows a steady upward trend from 2024 to 2028, with values rising from 1.73 billion USD in 2024 to 1.81 billion USD in 2028. Comparing these figures to 2023's base provides insight into growth patterns, indicating an average annual increase over the five-year period.
Year-on-Year Variations:
- 2024-2025: approximately 1.16% increase
- 2025-2026: approximately 1.14% increase
5-Year CAGR:
- The compound annual growth rate from 2024 to 2028 is estimated to be approximately 1.15%, reflecting a consistent upward trajectory.
Looking ahead, key trends to monitor include the impact of an aging population, advancements in treatment technologies, and potential policy changes affecting pharmaceutical pricing and reimbursement in Germany.
